mesenchymal stem cells

Scientists raise alarm as Italian Government rules on unproven stem cell therapy

An unproven stem cell therapy has taken centre stage in Italy after patients successfully lobbied the Italian government to allow its use in public hospitals. The highly controversial and untested procedure was created by the privately owned Stamina Foundation, but blocked by the Italian Medicine's Agency, AIFA. Last week's decision by the Ministry of Health to override AIFA's block has horrified Italy's leading stem cell scientists. In a letter to the Ministry, they describe the decision as providing "a dangerous short circuit between patients' hopes and lucrative commercial practices" of organisations operating outside the "scientific and moral foundations" of medicine.

Mezenchymalne komórki macierzyste

Last updated:
20 Jun 2012

Mezenchymalne komórki macierzyste (MKM), zwane po angielsku mesenchymal stem cells (MSC), mogą tworzyć kilka typów komórek należących do grupy tkanek szkieletowych takich jak chrząstka, kości lub tłuszcz. Naukowcy badają potencjalne zastosowanie MSC w celu leczenia chorób kości lub tkanki chrzęstnej. Część badań na MSC koncentruje się na leczeniu innych schorzeń, jednak naukowe podstawy takich badań nie zostały jeszcze ustalone lub powszechnie zaakceptowane.

Mesenchymale Stammzellen: die „anderen" Knochenmark-Stammzellen

Last updated:
20 Jun 2012

Mesenchymale Stammzellen (oder MSCs aus dem englisch) sind in der Lage verschiedene Zellarten des Körperskeletts, wie zum Beispiel Knorpel, Knochen und Fett, herzustellen. Wissenschaftler untersuchen wie MSCs verwendet werden könnten, um Knochen- und Knorpelkrankheiten wirksam zu behandeln. Einige MSC Forschergruppen erkunden auch Therapien für andere Krankheiten, aber die wissenschaftliche Grundlage für diese Anwendungen ist noch nicht ausreichend erforscht oder akzeptiert.

Les cellules souches mésenchymateuses : les “autres” cellules souches de moelle osseuse

Last updated:
20 Jun 2012

Les cellules souches mésenchymateuses (CSM) peuvent produire plusieurs types de cellules appartenant  aux tissus squelettiques, tels que le cartilage, les os et la graisse. Les scientifiques étudient comment les CSM pourraient être utilisées pour traiter les maladies des os et du cartilage. Des recherches avec les CSM étudient également des thérapies pour d'autre maladies, mais le fondement scientifique de ces applications n’a pas encore été établi ou largement accepté.

Células madre mesenquimales: las "otras" células madre de la médula ósea

Last updated:
20 Jun 2012

Las células madre mesenquimales (CMM) pueden producir varios tipos de células de los tejidos esqueléticos, tales como el cartílago, hueso y grasa. Científicos están investigando cómo las CMM pueden usarse para tratar enfermedades óseas y de cartílago. Algunas investigaciones basadas en las CMM están explorando terapias para otras enfermedades, pero la base científica de estas aplicaciones todavía no se ha establecido o aceptado ampliamente.

Mikey Creane: stem cell researcher in Galway

This is part 1 of REMEDI scientist Mikey Creane's guest blog for EuroStemCell. Read Mikey's other posts.

My name is Mikey Creane and I am currently a PhD student working at the Regenerative Medicine Institute (REMEDI) in the National University of Ireland Galway. I have volunteered to write this blog  “A Day In The Life Of A Stem Cell Researcher" as I thought it would be interesting to convey to both scientists and non scientists what it is like to be part of the world of stem cell research. This blog could not have come at a more perfect time considering the winners of the 2012 Nobel prize for medicine were two stem cell researchers

Mesenchymal stem cells: the 'other' bone marrow stem cells

Last updated:
20 Jun 2012

Mesenchymal stem cells (MSCs) can make several types of cells belonging to our skeletal tissues, such as cartilage, bone and fat. Scientists are investigating how MSCs might be used to treat bone and cartilage diseases. Some MSC research is also exploring therapies for other diseases, but the scientific basis for these applications has not yet been established or widely accepted.

Interview with Karen English: where cell biology and immunology meet

Karen is a post doctoral researcher in the lab of Prof. Kathryn Wood at the University of Oxford. Karen’s work contributes to the EC-funded project OptiStem. We caught up with Karen at the project’s 2011 annual meeting.

The Biotechnology Revolution: Can we cure with cells?

Take a trip to Montpellier to discover how scientists are working on an arthritis treatment to create a cure using MSCs, one type of adult stem cell. This short film is also available in Catalan.
Syndicate content